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Abstract.  Two peroxisome targeting signals (PTSs) 
for matrix proteins have been well defined to date. 
PTS1 comprises a COOH-terminal tdpeptide, SKL, 
and has been found in several matrix proteins, 
whereas PTS2 has been found only in peroxisomal 
thiolase and is contained within an NH2-terminal cleav- 
able presequence. We have investigated the functional 
integrity of the import routes for PTS1 and PTS2 in 
fibroblasts from patients suffering from peroxisome as- 
sembly disorders.  Three of the five complementation 
groups tested showed a general loss of PTS1 and PTS2 
import.  Two complementation groups showed a 
differential loss of peroxisomal protein import:  group I 
cells were able to import a PTS1- but not a PTS2- 
containing  reporter protein into their peroxisomes, and 
group IV cells were able to import the PTS2 but not 
the PTS1 reporter into aberrant,  peroxisomal ghostlike 
structures.  The observation that the PTS2 import path- 
way is intact only in group IV cells is supported by 
the protection of endogenous thiolase from protease 
degradation  in group IV cells and its sensitivity in the 
remaining  complementation groups,  including the par- 
tialized disorder of group I. The functionality of the 
PTS2 import pathway and colocalization of endoge- 
nous thiolase with the peroxisomal membranes in 
group IV cells was substantiated further using im- 
munofluorescence, subcellular fractionation,  and im- 
munoelectron microscopy. The phenotypes of group I 
and IV cells provide the first evidence for differential 
import deficiencies in higher eukaryotes. These pheno- 
types are analogous to those found in Saccharomyces 
cerevisiae peroxisome assembly mutants. 
p 
EROXISOMES are  ubiquitous  subcellular  organelles 
bounded  by  a  single  membrane.  Although  their 
protein content varies depending on the organism and 
cell type (Tolbert,  1981), a feature  common to all peroxi- 
somes is  the  presence  in  the  matrix  of hydrogen  perox- 
ide-producing  oxidases  and  other  enzymes  required  for 
/3-oxidation, and  catalase.  A  variety  of other biochemical 
functions has been assigned to peroxisomes (Lazarow, 1987; 
Van den Bosch et al., 1992; Mannaerts  and Van Veldhoven, 
1993),  and their  importance for cellular metabolism has 
been underlined by the occurrence of severe disorders in man 
caused by deficiencies  in peroxisomal functions  (Kelley et 
al.,  1986;  Schutgens  et al.,  1986;  Wanders  et al.,  1988; 
Lazarow and Moser,  1989;  Zellweger,  1989).  These dis- 
eases fall into three categories:  (a) the generalized disorders 
of peroxisome assembly, in which all peroxisomal functions 
investigated  are deficient;  (b)  the partialized  disorders of 
peroxisome assembly, in which the activity of a limited sub- 
set of peroxisomal enzymes is deficient;  and (c) disorders 
caused by a deficiency of a single peroxisomal  enzyme. 
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Complementation studies based on the recovery of peroxi- 
somal function after fusion of certain combinations  of pa- 
tients' fibroblasts indicate that the peroxisome assembly dis- 
orders  are  genetically  heterogeneous  (Brul  et  al.,  1988; 
Roscher et al.,  1989; Poll-The et al.,  1990; Yajima et al., 
1992). The complementation groups established by three re- 
search groups have recently been integrated  (Shimozawa et 
al.,  1993),  and  we have  investigated  protein  import  into 
peroxisomes in four of these complementation groups. The 
fibroblasts  belonging  to  these  complementation  groups, 
which we refer to using the Amsterdam nomenclature,  are 
derived from patients suffering from the generalized  impair- 
merits  of peroxisome  assembly.  Morphologically  distin- 
guishable peroxisomes, visualized  as particle-bound cata- 
lase,  are  virtually  absent  (Goldfischer  et  al.,  1973). 
Immunoblots have shown that the levels of the/~-oxidation 
enzymes are strongly reduced ('Pager et al,, 1985; Suzuki et 
al.,  1986;  Suzuki  et  al.,  1988),  and  these  proteins  are 
thought to be degraded in the absence of import into peroxi- 
seines. At least some peroxisomal membrane proteins,  how- 
ever, are present in atypical structures that have been.termed 
ghosts (Santos et al.,  1988a,  1988b; Wiemer et al.,  1989). 
In electron micrographs,  these structures are two to four 
times larger than peroxisomes from control cells, and they 
appear to lack content (Santos et al.,  1988a).  Subcellular 
fractionation  experiments  have  shown  that  peroxisomal 
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control cells (Santos et al., 1988a; Gartner et al., 1991; Van 
Roermund et al.,  1991). 
In addition to the generalized disorders of peroxisome as- 
sembly, in our analysis, we have also included cells derived 
from patients suffering from a partialized disorder of  peroxi- 
some  assembly:  rhizomelic  chondrodysplasia  punctata 
(RCDP) 1 (Heymans et al.,  1985 and 1986;  Hoefler et al., 
1988;  Poulos  et  al.,  1988),  which  comprises  our  com- 
plementation group I  (Brul et al.,  1988;  Heikoop et al., 
1992c).  Classical RCDP is characterized biochemically by 
the following features: first, there is a deficiency of the first 
two enzymes of plasmalogen biosynthesis; second, there is 
an inability to catabolize phytanic acid, and finally, there is 
a failure to convert the precursor form of thiolase to the ma- 
ture form of the enzyme. The morphology of peroxisomes, 
however,  appears to be normal in RCDP fibroblasts (Hei- 
koop et al., 1991), and catalase is present in the matrix. Sub- 
cellular fractionation has shown that the peroxisomes from 
RCDP fibroblasts fractionate at the same density as peroxi- 
somes from control cells, while precursor thiolase is present 
in lower density fractions in RCDP cells (Balfe et al., 1990; 
Singh et all.,  1991; Heikoop et al.,  1992a). 
The aim of our research was to further analyze the mutant 
phenotypes in each of the complementation groups by inves- 
tigating the functional integrity of the import routes for the 
two well-defined peroxisome targeting signals (PTS) for ma- 
trix proteins: the PTS1 is comprised of a COOH-terminal 
tripeptide, SKL, and derivatives thereof. The PTS1 was first 
found at the COOH terminus of the firefly enzyme luciferase 
(Gould et al., 1987), and the PTS1 has since been found on 
a  number  of peroxisomal matrix proteins  (Gould et al., 
1988).  The PTS2 was first identified on rat 3-ketoacyl-CoA 
thiolase (Swinkels et al., 1991; Osumi et al., 1991), and is 
located within an NH2-terminal sequence that in mammals 
is cleavable.  That proteins containing either PTS1 or PTS2 
enter the peroxisome by different import routes is reflected 
by the phenotypes of some of  the yeast peroxisome assembly 
mutants: Saccharomyces cerevisiae pas7 can import  SKL 
proteins but not thiolase into its peroxisomes (Van der Leij 
et al., 1992; Erdmann and Ktmau, 1993),  and S. cerevisiae 
paslO (Van der Leij et al., 1992,  1993) and t~chiapastoris 
pas8 (McCollum et al.,  1993) can import thiolase but not 
SKL proteins.  In other complementation groups,  neither 
thiolase nor SKL proteins are imported (Van der Leij et al., 
1992; Zhang et al., 1993). How the peroxisomal membrane 
proteins are targeted to the organelle is still unknown, and 
additional ITS motifs for this class of proteins remain to be 
identified. 
We have investigated import via the PTS1 in human fibro- 
blasts using luciferase as  a  reporter  protein.  A  prethio- 
lase-cldoramphenicol acetyltransferase (CAT)  fusion pro- 
tein was used as a reporter for import via the PTS2 route. 
The reporter proteins were produced from expression con- 
structs introduced into the nucleus of cells by microinjec- 
tion. Our investigation into the PTS1 and PTS2 import routes 
1. Abbreviations used in this paper: CAT, chioramphenicol acetyltransfer- 
ase; PAF, peroxisome-assembly  factor; PMP, peroxisome  membrane pro- 
tein; PTS, peroxisome  targeting signal; RCDP, rhizomelic form of chow 
drodysplasia  punctata; TRITC,  Texas red isothiocyanate. 
shows that phenotypes analogous to those of the yeast mu- 
tants can be found among the human peroxisome assembly 
disorders.  The observation that either one of the import 
routes can be deficient  provides the first evidence that the two 
import routes for matrix proteins can be impaired indepen- 
dently of each other in the human peroxisome assembly dis- 
orders. 
Materials and Methods 
Cell Cultures 
Cultured primary skin tibroblasts used in these studies were from two con- 
trol subjects  (cell lines 85AD5035F  and HENG90AD) and from patients 
suffering from the clinical and biochemical features characteristic of the fol- 
lowing peroxisomal disorders: (a) RCDP, complementation group I (cell 
lines MCHE  85AD  and GJOLD90AD);  (b) Zellweger syndrome,  com- 
plementation group II (cell lines W78/515  and BOV 84AD),  group Ill 
(GOM 85AD and GM 4340), and group V (GRO 87AD); (c) hyperpipecolic 
aeidemia,  group  lI  (cell  line  GM  3605);  (d),  the  neonatal  form  of 
adrenoleukodystrophy,  group IV (cell line AAL 85AD). Cells were grown 
in a  1:1 mixture of Dulbeceo's  modified  Eagle's  medium and Ham's F10 
(Gibco Laboratories, Glasgow, United Kingdom)  supplemented with 10% 
fetalcalf serum (Gibco Laboratories) under 5% CO2. Cells were split 1:4 
as soon as they reached confluence, as allowing the cells to remain confluent 
has been shown to increase the amount of immunoreactive thiolase in the 
cells (Wiemer et al.,  1991). Cells were not used above passage 30, as an 
increased frequency  of punctate fluorescence  has been observed in aging 
cells (unpublished observations). 
Microinjection 
24 h before microinjection, the cells were plated onto microinjection  grids. 
The needles were made using a micropipette puller (PB-7; Narishage Co., 
Tokyo),  and DNA was injected in reverse PBS (4 mM Na2HPO,  dl mM 
KI-I2PO4]I40 mM KC1, pH 7.3).  DNA was injected at a concentration of 
"-4).1 #g/ml, which is equivalent to "°50 mol DNA per injection.  18 h after 
microinjection, the cells were processed for immunofluorescence  micros- 
copy. Approximately  200 cells were injected per cell line per experiment, 
'~20 % of which survived injection and gave rise to detectable expression. 
SubceUular Fractionation 
Seven to nine 150-cm  2 flasks of cells were used per gradient. The cells 
were harvested by gentle trypsinization and collected by low-speed centrifu- 
gation. The cells were then washed twice in PBS and once in ice-cold 
homogenization  buffer (0.25 mM sucrose/0.1 mM EDTA/1 mM Tris-HCl, 
pH 7.8),  and postnuclear supernatants were prepared as previously  de- 
scribed (Van Roermund et al.,  1991). Subsequently,  equilibrium density 
centrifugation was performed as described (Van Rocrmund et al., 1991) by 
layering 4 ml of  the pestuuclear supernatant (containing '~25 nag of  protein) 
on top of a preformed 33-ml gradient of Nycodenz (10-35 %). All Nyendenz 
solutions were prepared in homogenization buffer. Centrifugatiun was car- 
ried out in an MSE-Europe 24M centrifuge (M.S.E. Scientific Instruments, 
Crawley,  United Kingdom)  equipped with a ve~cal rotor for 90 rain at 
19,000 rpm at 4°C. Fractions were collected from the bottom of the gradi- 
ent and analyzed for the activity of the marker enzymes glutamate deby- 
drogenase (mitochondria), catalase (peroxisomes),  and/3-hexosaminidase 
(lysosomes).  Activities are expressed as percentages of total activity across 
the gradient. 
Proteinase K Protection 
The proteinase K protection experiments were performed on fibroblasts per- 
meabilized by 125 ~g/ral digitonin in permeabllization buffer. After har- 
vesting the cells by trypsinization, the fibroblasts were washed twice in cold 
PBS and resuspended to a protein concentration of '~1 mg/ml in isotonic 
sucrose buffer (250 mM sucrose,  20 mM MOPS, pH 7.4), containing 125 
#g/mi digitonin (penneabillzation buffer).  The fibroblasts  were then in- 
cubated for 5 min at 37°C in the digitonin permeabilizatinn  buffer, as previ- 
ously described (Heikoop  et al.,  1990).  This concentration of digitonin 
causes rupture of the plasma membrane (and perhaps also some intracellu- 
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remains intact (Wanders ct al., 1984; Aikawa ct al., 1991). This is indicated 
by the fact that the cytosolic marker lactate dehydrogenase  was present in 
the soluble fraction, whereas eatalase activity was present in the sediment- 
able fraction (10,000 g, 5 min) of both control and RCDP cells. After per- 
meab'dization  of the plasma membrane, the protease protection assay was 
carried out on ice using a proteinase K concentration of 40/~g/ml in the 
presence or absence of  0.2 % Triton X-100. Samples were removed after 0. 5, 
1, and 1.5 h, and proteinase K action was stopped by addition of PMSF to 
10 raM. Protection of thiolase was assessed by immunoblot analysis. 
Immunoblot Analysis 
Samples were subjected to electrophoresis on 10% polyacrylamide gels ac- 
cording to the method of Iatemmli. lmmunoblot analyses were performed 
as described previously with the following modifications:  Nonspecific bind- 
ing sites were blocked overnight with 10% fetal calf serum in TBS (10 mM 
Tris pH 8/150 mM NaC1) containing 0.2%  Tween 20. The primary (poly- 
clonal antithiolase) (Heikoop et ai., 1990) and secondary (horse radish per- 
oxidase coupled to goat anti-rabbit  IgG 0Bio-Rad Laboratories, Richmond, 
CA) antibody incubations were performed in TBS containing 4% fetal calf 
serum and 0.1% Tween 20. After each incubation, the blots were washed 
extensively in TBS containing 0.1% Tween 20. Antigen-antibody  complexes 
were visualized using the electrochemilumineseence kit from Amersbam 
International (Den Bosch, The Netherlands). 
Immunofluorescence Microscopy 
For labeling of the peroxisomal compartment, cells were washed  in PBS and 
fixed in freshly prepared 2% (wt/vol) p-formaidehyde/0.1%  Triton X-100/ 
PBS (pH 7.5) for 20 rain at room temperature.  For differential permeabfliza- 
tion, the ceils were fixed in 2 % paraformaldehyde  in PBS for 20 rain and 
permeabilized with 25/~g/mi digitonin in PBS (which permeabflizes the 
plasma membrane only) or 25/Lg/ml digitonin in PBS containing 0.1% Tri- 
ton X-100 (to permeabilize both the plasma membrane and the peroxisomal 
membrane). 25/~g/ml digitonin is sufficient to permeabilize the plasma 
membrane of adhering cells because of the relatively low protein concentra- 
tion (125 ~g/ml was used to permeabilize cells in suspension at a protein 
concentration of 1 mg/mi [see section on "Proteinase K Protection"]).  For 
double labeling of peroxisomes and lysosomes, the cells were fixed by a 10- 
win incubation at room temperature in 4 mi 3 % paraformaldebyde in PBS, 
pH 7.5, followed by a 5-rain incubation a~er addition to the 4 ml parafor- 
maldehyde of  2 ml cold (-20%) methanol, followed by a final 5-rain incuba- 
tion after a further addition of 2 ml cold methanol. The fixative was then 
aspirated, and the cells were washed three times in PBS containing 0.05 % 
Triton X-100. 
Free aldehyde groups were blocked by incubating for 10 min in 0.1 M 
NI-~C1 in PBS. The cells were then processed for single- or double-label 
indirect immunofluorescence using the following antibodies: mouse mono- 
clonal antithiolase (3G4) (Heikoop  et al.,  1991), polyclonal  anti-69-kD 
peroxisomaI  membrane protein (PMP) 0~ster et al.,  1986) (a kind gift 
from Dr. W. Just, Institut fiir Biochemie, Heidelberg,  Germany), polyclonal 
(guinea pig) antiluciferase (Keller et al.,  1987),  and pelycfonal  (rabbit) 
anti-chloramphenicol acetyltransferase (Sanvertecb,  Boechout, Belgium). 
For double labeling of luciferase and 69-kD PMP, 69-kD PMP was visual- 
ized with FITC-conjugated donkey anti-rabbit (Jackson ImmunoResearcb 
Laboratories, West Grove,  PA),  and luciferase was visualized using bi- 
otinylated goat anti-guinea pig IgG (Sigma lmmunochemicals, Bornam, 
Belgium)  followed  by  streptavidin-labeled  Texas red  isothiocyanate 
(TRITC)  (Amersham International). For double labeling of either 69-kD 
PMP or prethiolase-CAT  with monoclonal antithiolase antibodies, the sec- 
ondary  antibodies used  were  FITC-conjugated  donkey  anti-rabbit IgG 
(Jackson ImmunoResearch  Laboratories)  and  biotinylated sheep  anti- 
mouse  Ig  (Amersham  International),  followed  by  streptavidin-labeled 
TRH~ (Amersham International). For double labeling of peroxisomai thio- 
lase and lysosomai glucocerebrosidase,  peroxisomal thiolase was visualized 
with biol~ylated sheep anti-mouse Ig (Amersbam International) followed 
by streptavidin-labeled TRITC  (Amersbam International), and lysosomes 
were visualized using rabbit antiglucocerebrosidase (kind gift from Dr. H. 
Aerts, E. C  Slater Institute, Amsterdam) followed by FITC-coujugated dun- 
key anti-rabbit IgG (Jackson  ImmunoResearch Laboratories). For single 
labeling, biotinylated secondary antibodies were used followed by strepta- 
vidin-labeled FITC (Life,  Breda, The Netherlands). 
The incubations were all performed at room temperature for 45 rain in 
PBS containing l0 mg/mi bovine serum albumin (to reduce nonspecific 
binding). After each incubation, the ceils were washed extensively in PBS. 
The  injection grids  were  mounted on  coverslips  in carbonate-buffered 
glycerol  containing p-phenylenediamine. The fluorescent staining pattern 
was viewed in a fluorescence  microscope (model IM'I2; Olympus Corp., 
Lake Success,  NY), using an IMT2DMB filter for excitation of the FITC 
signal, and an IMT2-DMG for excitation of the TRITC  signal.  FITC 
fluorescence was visualized in combination with the G520 barrier filter and 
TRII~ fluorescence  in combination with the 13610 barrier filter. Fluores- 
cent images were recorded on AGFA 400 ASA slide film or Kodak TMAX 
400 ASA B/W film. 
Electron Microscopy 
Fixation of fibmblasts and preparation of ultrathin cryusections  were per- 
formed exactly as described by Wiemer et ai. (1989). Immunolabeling was 
performed as described previously with the following modifications.  For 
double labeling with anti-69 kD PMP (rabbit polyclonal)  and anfithiolase 
(mouse monoclonal), the sections were first incubated with antithiolase fol- 
lowed by rabbit anti-mouse IgG, followed by protein A-conjugated, 1O-nm 
colloidal gold.  Residual binding sites were blocked with protein A. Sec- 
ondly, the sections were incubated with anti-69 kD PMP followed by pro- 
tein A conjugated  with 5 nm of colloidal  gold.  Afar each incubation the 
grids were washed with PBS. The tissue sections mounted on the grids were 
poststained and embedded in a 0.3%  uranyl acetate/1.5%  mcthylcellniose 
mixture and dried in air. Grids were examined under a transmission elec- 
tron microscope (model 420; Philips Electronic Instruments, Inc., Mah- 
wah, NJ). 
Construction of Vectors 
The construction of pCDNALuc was as follows:  the luciferase ORF was 
cut out of pDDR (Riggs and Chrispeels, 1987) with Sinai and HindIII, and 
the ends of this fragment were made blunt with the Klenow  fragment of 
DNA polymerase I. BstXI adaptors were ligated to this fragment, which 
was then cloned into the BstXI site of the expression vector pCDNA. The 
expression plasmid encoding the first 15 amino acids of rat thiolase fused 
onto bacterial chloramphenicol acetyltrausferase  (pRSV-FLT3-CAT) was a 
kind gift from S. Subramani (University of California, San Diego, CA) and 
is described by Swinkels  et al. (1991). 
Results 
Our strategy to investigate peroxisomal protein import in the 
peroxisome assembly disorders involved microinjection  into 
the nucleus of expression constructs encoding reporter pro- 
reins  for  the PTS1 or  PTS2  import routes.  We chose to 
microinject  DNA rather than RNA or protein because the 
prolonged expression period after microinjection of DNA al- 
lows the cells time to recover from the trauma of microinjec- 
tion before detection of the antigen by immunofluorescence. 
Expression of luciferase  could still be detected  48 h after 
microinjection  of the DNA. Microinjection trauma is mini- 
realized  because only '~50 molecules of DNA need to be 
CMV  l~  Ludferase 
=  -  ~"  _  "  "  _  '  pA 
RSV ~  Prethio-CAT 
pA 
Figure 1.  Constructs used to determine import via the PTS1  (lu- 
ciferase) or PTS2 (prethiolase-CAT) import routes. Stippled boxes, 
reading frames of the reporter proteins;  thin  lines,  plasmid se- 
quences; •,  the promoter (CMV, cytomegalovirus; ~  Rous sar- 
coma virus); pA, the polyadenylation sequence. For details of con- 
struction, see Materials and Methods. 
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in Complementation Groups I-V 
Complementation group according 
to nomenclature of: 
Targeting  of  Targeting of 
Amsterdam  Baltimore  Oifu  luciferase  prethiolase-CAT 
I  (RCDP)  +*  - 
II  1  E  -  - 
HI  4  C  -  - 
IV  2  -  -  +* 
V  -  F  -  +* 
Our complementation  groups have been  integrated  with those  of Baltimore 
(Roschex et al.,  1989) and Gifu  (Yajima et at.,  1992) by Shimozawa et al. 
(1993). 
° Import into peroxisomes  that  appear  morphologically  normal  and  contain 
catainse (Heikoop et el.,  1991). 
~; Import into peroxisomal ghosts (Santos et at., 1988a and 1988b; Wiemer et 
al.,  1989). Targeting  of prethiolase-CAT  to peroxisomal  ghosts in group V 
cells is very weak and can only be detected in 25-50%  of the cells expressing 
the reporter protein. 
injected per cell to assess import. The high sensitivity of the 
system is a  reflection of the amplification by transcription 
and translation steps,  and of the strength in human fibro- 
blasts of the promoters used (cytomegalovirus and Rous sar- 
coma virus)  (Fig.  1). 
PTS1 comprises a COOH-terminal tripeptide, SKL, and 
firefly luciferase was chosen as the reporter protein for this 
import route. A prethiolase-CAT fusion protein was used as 
the reporter protein for import via the PTS2 route. Targeting 
was assessed by processing the cells for immunofluorescence 
18 h after microinjection of the expression constructs encod- 
ing the reporter proteins. In control cells, expression of both 
the PTS1 and PTS2 reporter proteins gave rise to a punctate 
pattern of labeling (Fig. 2, A and C), which was taken to be 
indicative of targeting: targeting of the reporter proteins to 
a  peroxisomal compartment was assessed by double-label 
immunofluorescbnce using  antibodies directed against  the 
69-kD PMP, a well-established marker of the peroxisomal 
membrane (Fig. 2 B). 
Targeting via the PTS1 and PTS2 Routes 
in Groups I-V 
Luciferase expressed in complementation group I cells gave 
rise to a pattern of labeling indistinguishable from that in 
control cells, and the peroxisomal nature of this compart- 
ment was confirmed by colocalization with the 69-kD per- 
oxisomal membrane protein (Fig. 2, D and E). Complemen- 
tation groups II-V all contain peroxisomal ghosts (Fig. 2, H, 
K, N, and Q, respectively), indicating that targeting of the 
69-kD peroxisomal membrane protein is still functional in 
the complementation groups used in this study. However, lu- 
ciferase expressed in cells from groups II-V gave rise to a 
Figure 3. Precursor thiolase is protected from degradation by pro- 
teinase K in group IV cells only. Fibroblasts from a control subject 
and from each of the complementation groups were permeabilized 
with 125 ttg/ml digitonin and incubated at 4°C for the times indi- 
cated in the presence or absence of 40 t~g/ml proteinase K and Tri- 
ton X-100, which was added to disrupt intracellular membranes. 
0.2% Triton was sufficient to observe digestion of precursor thio- 
lase in group IV cells, whereas 0.5% Triton was required before 
digestion of mature thiolase was observed in control cells. The ar- 
rows indicate the positions of precursor thiolase (44 kD) and ma- 
ture thiolase (41 kD). 
pattern of labeling characteristic for a protein with a cyto- 
plasmic location (Fig. 2, G, J, M, and P), and no association 
with the peroxisomal membranes could be detected. Identi- 
cal patterns of staining were seen after expression of CAT- 
SKL (not shown), a second reporter protein for the SKL im- 
port route. 
Expression  of prethiolase-CAT  in  cells  from  comple- 
mentation  groups  I-l]/  gave  rise  to  a  diffuse pattern  of 
fluorescence (Fig.  2, F, I, and L); no association with the 
peroxisomal  membranes  could  be  detected,  not  even  in 
complementation group I  fibroblasts,  which contain mor- 
phologically normal, catalase- and luciferase-positive per- 
oxisomes. Prethiolase-CAT expressed in complementation 
group V fibroblasts gave rise to a weak particulate pattern 
of  labeling in only some (25-50%) of  the cells expressing the 
reporter protein (Fig.  2  R),  the expression pattern being 
diffuse in the remaining cells. In group IV cells, however, the 
PTS2 reporter protein gave rise to a strong particulate pat- 
tern  of labeling  in  virtually  all  the  cells  expressing  the 
reporter protein (Fig. 2 O): the structures labeled resemble 
peroxisomal ghosts (Fig.  2 N).  These results are summa- 
rized in Table I. 
Figure  2. Panctate fluorescence as an indication for import of  the reporter  proteins into peroxisomes. The subcelhilar localization of  lu¢ifer- 
ase (left pane/s), 69-kD PMP (center  panels  ), and prethiolase-CAT (r/ght pane/s).is shown in fibroblasts from a control subject (C) and 
from complementation groups I-V (I-V). Luciferase (PTS1 reporter) and prethiolase-CAT (PTS2 reporter) were produced in the cells from 
microinjected expression constructs. Double labeling in control (.4, B) and group I (D, E) ceils shows that luciferase coloealizes with the 
69-kD PMP, whereas the pattern of immunofluorescence in groups II-V expressing luciferase is diffuse (G, J, M, and P). Expression of 
prethiolas~CAT gives rise to a pattern of fluorescence that in groups I-HI is diffuse (F, 1, and L), in group IV is particulate (O), and 
in group V is sometimes weakly particulate (R) and sometimes diffuse. 
Morley et at. Peroxi$omal Protein Import Deficiencies  759 The Journal of Cell Biology, Volume  125, 1994  760 Figure 5. Colocalization of prethiolase-CAT, 69-kD PMP and endogenous thiolase using double-label immunofluorescence.  Prethiolase- 
CAT (A) colocalizes with endogenous thiolase (B) in group IV cells expressing the PTS2 reporter protein, and endogenous thiolase (C) 
colocalizes with 69-kD PMP in group IV cells (D). 
Protease Protection of  Endogenous Thiolase 
in Groups I-V 
If  import via the PTS2 pathway is intact, thiolase will be pro- 
tected from protease digestion because of  its presence within 
the peroxisomal membrane. Protease protection experiments 
were performed on digitonin-permeabilized cells to inves- 
tigate the stability of endogenous thiolase in the five com- 
plementation  groups.  Digitonin  disrupts  membranes  by 
complexing to cholesterol: we have used 125 ttg/ml digito- 
nin, and under these conditions, the plasma membrane (and 
other cholesterol-rich membranes) arc permeabilized, but 
the peroxisomal membrane, which contains relatively little 
cholesterol, remains intact (Wanders et ai., 1984; Aikawa et 
ai., 1991). As shown in Fig. 3, fibroblasts from complemen- 
ration groups I-V contain only the precursor form of  thiolase 
(44  kD).  In each of the complementation groups  except 
group IV, precursor thiolase was degraded in the absence of 
Triton  X-100;  in  complementation  group  IV,  however, 
precursor thiolase remained protected from protease diges- 
tion at each of the time points investigated, which suggests 
that it is present within a membrane. 
Because the immanofluorescence and protease protection 
experiments suggest that targeting and import via the PTS2 
Figure 4. Detection of  endogenous  thiolase using a monoclonal antibody. (A) Control fibroblasts; (B-F) fibroblasts  from groups l-V, respec- 
tively. A typical  pcroxisomal labeling  pattern  is  seen in  control  cells  (A),  a  very weak, diffuse  pattern  of  labeling  is  found in  groups  I-HI 
(B-D), a strong  particulate  pattern  of  labeling  in  group  IV (E),  and a  weak pattern  of  labeling  in  group  V cells  (F),  which in  some cells 
is  particulate  and in some cells  is  diffuse. 
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were performed to further substantiate these observations. 
ConJirmation of Thiolase Targeting to Peroxisomes  in 
Group IV Cells 
The observations made using the trrS2 reporter protein were 
supported when endogenous thiolase in the cells was visual- 
ized using a monoclonal antibody directed against peroxi- 
somal thiolase. When processed for antithiolase immunoflu- 
orescence, cells from complementation groups I-IH showed 
a very weak, diffuse pattern of labeling (Fig. 4, B, C, and 
D, respectively) (I-Ieikoop et al.,  1992c).  In complementa- 
tion group V  cells, a  weak pattern of labeling was seen, 
which in some cells was particulate and in some cells was 
diffuse (Fig 4 F). In complementation group IV cells, how- 
ever, a strong particulate pattern of labeling was seen, and 
the structures labeled resembled peroxisomal ghosts (Fig. 4 
E). Double-labeling immunofluorescence showed that pre- 
thiolase-CAT  expressed  after  microinjection  (Fig.  5  A) 
colocalizes with endogenous thiolase in group IV cells (Fig. 
5 B). 
To  determine  whether  endogenous thiolase colocalizes 
with the peroxisomal membranes in group IV cells, double- 
labeling immunofluorescence using the antithiolase mono- 
clonal and the anti-69 kD PMP polyclonal antibody was per- 
formed. Fig. 5 shows that the thiolase immunoreactivity in 
group IV cells (C) indeed colocalizes with the peroxisomal 
membranes (D). 
Thiolase is Imported into Peroxisomal  Membranes in 
Group IV Cells 
Differential permeabilization with digitonin (25 ~g/ml) fol- 
lowed  by  immunofluorescence  was  used  to  determine 
whether prethiolase-CAT is present on the inside or the out- 
side of  the peroxisomal membrane in group IV cells express- 
ing the PTS2 reporter protein. When the plasma membrane 
was permeabflized using low concentrations of digitonin, 
epitopes exposed only to the cytoplasm were accessible to 
labeling by an antibody. Under these conditions, antibodies 
directed against the 69-kD  PMP  labeled the peroxisomal 
membranes (Fig. 6 A), whereas a diffuse pattern of labeling 
was observed using anti-CAT antibodies in cells expressing 
the PTS2 reporter protein (Fig. 6 B). When Triton X-100 
was included in the permeab'dization, both the plasma mem- 
brane and the peroxisomal membrane were permeabilized. 
Under these conditions, particulate prethiolase-CAT could 
be detected (Fig. 6 C). The same results were obtained using 
an antithiolase monoclonal antibody to detect endogenous 
thiolase (not shown);  thiolase labeling could be detected 
Figure  6.  Differential permeabilization shows that  the  PTS2 
reporter protein is present inside the peroxisomal membranes in 
group IV cells. Differential  permeabilization was performed using 
25  /s.g/ml digitonin, which permeabilizes the plasma membrane 
only, or digitonin plus Triton X-1O0, which permeahilizes both the 
plasma membrane and the peroxisomal  membrane. (A) Staining for 
69-kD PMP labels the peroxisomal membranes in group IV cells 
permeabilized with  25  ttg/ml  digitonin.  (B)  When  the  PTS2 
reporter protein is labeled in group IV cells permeabilized with 25 
/zg/ml  digitonin, a diffuse  pattern of  labeling is seen. (C) When Tri- 
ton and digitonin are used to permeahilize group IV cells express- 
ing the PTS2 reporter protein, a particulate pattern of labeling of 
prethiolase-CAT can be detected. 
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dients shows that the peroxisomal ~ghosts  " in group IV cells equili- 
brate in a low density fraction. Fractionation of (,4) control and (B) 
group  IV fibroblasts.  =,  catalase;  o,  glutamate  dehydrogenase 
(mitochondria); o,/~-hexosaminidase  (lysosomes). Catalase (and 
other peroxisomal enzymes [not shown]) peak in fractions 6 and 
7 in control cells (A), with a small amount of catalase present at 
the top of the gradient. In Group IV cells (B), catalase is present 
exclusively at the top of the gradient, lmmunoblotting of group IV 
subcellular fractions (C) shows that precursor thiolase and 69-kD 
PMP peak in fractions  11 and 12. 
only if Triton X-100 was included in the permeabilization. 
The  ability  to  detect  a  particulate  staining  pattern  for 
prethiolase-CAT and  endogenous thiolase  only when  the 
peroxisomal membrane is permeabilized indicates that the 
ZIS2-containing proteins are present inside the membrane. 
Group IV Ghosts Fractionate at Low Density 
Several investigations have indicated that peroxisomal ghosts 
fractionate at a lower density than peroxisomes from control 
cells (Santos et al.,  1988; Gartner et al.,  1991; Van Roer- 
mund et al., 1991). Subcellular fractionation was performed 
Figure 8.  Most peroxisomal ghosts do not colocalize with lyso- 
somes in group IV cells. Double-label immunofluorescence shows 
the subcellular localization of thiolase (A) and glucocerebrosidase 
(B) in group IV cells. Superimposition of the pattern of labeling 
in (,4) onto that in (B) shows that most of the thiolase-containin~ 
particles do not colocalize with lysosomes. The arrow indicates an 
area in which there is clearly no overlap of  these two compartments. 
to investigate whether the prethiolase-containing particles in 
group IV cells also fractionate at a lower density than peroxi- 
somes from control cells. Fig. 7 indicates that this was the 
case. In control  cells,  peroxisomes equilibrated  in  fractions 
6 and 7, and they were well separated from the other organel- 
lar peaks  (Fig.  7  A).  In complementation group IV cells, 
however, catalase activity was found at the top of  the gradient 
(Fig. 7 B), which is compatible with the diffuse pattern of 
labeling seen when catalase is visualized in group IV cells 
using immunofluorescence (Brnl et al., 1988). In contrast to 
catalase, however, thiolase and the 69-kD PMP immunore- 
activities migrated into the gradient and peaked in fractions 
11 and 12 (Fig. 7  C),  showing overlap with the lysosomal 
marker enzyme activity. Overlap with the lysosomai corn- 
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II and llI using double-label electron microscopy (Heikoop 
et al., 1992b). Heikoop et ai. found that >~80% of the 69-kD 
PMP-containing peroxisomal ghosts showed labeling  with 
anti-a-glucosidase  and  antiglucocerebrosidase,  indicating 
that most of these structures are lysosomal compartments in 
groups II and 1-ft. We have investigated whether the thiolase 
labeling in group IV cells overlaps with that of the lysosomal 
enzyme  glucocerebrosidase using  double-labeling  immu- 
nofluorescence.  As shown in Fig. 8, the immunofluorescence 
staining  patterns are strikingly  different in general  appear- 
ance, and most of the particles staining  for thiolase  (A) are 
clearly  separated  from the  glucocerebrosidase-containing 
lysosomes (B). Santos et al. (1988b) also found that most of 
the peroxisomal ghosts do not colocalize with lysosomes in 
the Zellweger cell lines that they studied. 
Thiolase Labeling is Associated with Multiple 
Membranes in Group IV Cells 
Double-label electron microscopy was performed to inves- 
tigate  whether a membrane could be visualized associated 
with the thiolase labeling  in group IV cells.  The electron 
micrographs shown in Fig.  9 clearly indicate  that thiolase 
labeling is enclosed by a membrane that contains the 69-kD 
PMP. Many of the residual "organelles" found were bounded 
by more than one membrane, and in these cases, the thiolase 
labeling is localized more to the periphery of the organdie. 
Several of the "organelles" appear to contain internal  mem- 
branes, which in one example separate differences  in elec- 
tron  density  in  the matrix.  The  appearance of these or- 
ganelles is reminiscent  of the thiolase-containing  organelles 
found in the S. cerevisiae mutant paslO (Van der Leij et al., 
1992). 
Discussion 
A promising line of research to gain insight into peroxisome 
biogenesis and the role of the components contributing  to it 
is the characterization  of ceils impaired in the assembly of 
the organdie.  Such cells are available in the form of fibro- 
blasts derived from patients who suffer from peroxisome as- 
sembly disorders.  We have  studied the capacity of these 
fibroblasts to import PTS1- or PTS2-containing  proteins into 
peroxisomes or residual peroxisomal structures by microin- 
jection of plasmids  encoding reporter proteins for each im- 
port pathway. Our results support the existence of differential 
import deficiencies:  (a) loss of PTS1 import (complementa- 
tion group IV); (b) loss of PTS2 import (group I); and (c) 
loss of both import routes (groups  II, 1]/, and V). 
Loss of PTS1 import  in  complementation  group IV,  a 
"generalized" disorder of peroxisome assembly, is shown by 
the incompetence of the peroxisomal membranes in group 
IV cells to import luciferase produced from a microinjected 
expression plasmid. This result agrees with and extends the 
observation made by Walton et al. (1992) that microinjected 
luciferase protein fails to be imported in two Zellweger cell 
lines.  Notwithstanding  the presence of ghostlike residual 
peroxisomal structures  in group IV cells,  which are gener- 
ally considered to be import incompetent, we have found that 
the PTS2 import pathway is still functional.  This is based on 
the following observations:  (a) prethiolase-CAT gives rise to 
punctate  fluorescence;  (b)  prethiolase-CAT  can  be  un- 
masked to give punctate fluorescence only after permeabili- 
zation  of the  peroxisomal  membrane  in  the presence  of 
Triton X-100; (c) endogenous thiolase is protected from pro- 
tease digestion  in  permeabilized group  IV cells;  and  (d) 
prethiolase-CAT  and  endogenous  thiolase  colocalize with 
69-kD PMP-containing  membranes  in group IV  cells as 
shown  by  immunofluorescence,  immunoelectron  micros- 
copy, and Nycodenz gradient subcellular fractionation.  Fur- 
thermore,  the possible presence of the bulk of the peroxi- 
somal structures in group IV cells within  lysosomes was 
excluded by the absence of colocalization  with the lysosomal 
enzyme glucocerebrosidase. Taken together, these results in- 
dicate that group IV is a true differential  import mutant. A 
similar phenotype has been demonstrated in the S. cerevisiae 
peroxisome  assembly  mutant paslO.  In  both  cell  types, 
peroxisomes axe reduced to abnormal-looking  membranous 
structures  that  are  capable of importing  thiolase  but not 
SKL-containing  proteins.  The PASIO gene has been cloned 
by functional complementation of the paslO mutant (Van der 
Leij et al., 1993), and a homologue has been characterized 
from P. pastoris (McCollum et al., 1993). It encodes a pro- 
tein of the tetratricopeptide repeat family that directly rec- 
ognizes  the  SKL import  motif (McCollum et al.,  1993) 
(Franse,  M.  M., personal communication),  supporting  its 
direct role in the protein import process. Antibodies raised 
against the S. cerevisiae PAS10 protein recognize a specific 
peroxisomal protein from rat liver and human fibroblasts, 
and we are currently cloning the cDNA encoding this pro- 
tein, This will enable us to test the interesting  possibility of 
whether group IV cells can be complemented by expression 
of the PAS10p homologue. 
Loss of PTS2  import  is observed in  complementation 
group I (RCDP) fibroblasts.  This is based on (a) the lack of 
detectable import of prethiolase-CAT  after expression of the 
PTS2 reporter protein in group I fibroblasts;  and (b) the sen- 
sitivity of endogenous  thiolase to protease digestion in per- 
meabilized group I cells. The competence of the PTS1 path- 
way can  be inferred  from the  equilibration  of acyl-CoA 
oxidase (an SKL-containing  enzyme) at normal density after 
subcellular fractionation  of RCDP cells (Balfe et al., 1990), 
and it is confirmed by the appearance of punctat¢  fluores- 
cence after expression of luciferase in group I cells. The rea- 
son this differential protein import loss has not been noted 
before may be because of the finding by Balfe et al.  (1990) 
that precursor thiolase present in low density fractions of an 
RCDP subcellular gradient is resistant to proteinase K diges- 
tion. In contrast, we have found that precursor thiolase is not 
protected from degradation by proteinase K in permeabilized 
RCDP (group I) ceils.  The clinical  phenotype of RCDP is 
Figure 9. Colocalization  of  69-kD PMP and thiolase in aberrant membranous structures in group IV cells. 69-kD PMP, 5 nm gold; thiolase, 
10 am gold. The e|eetron micmgraphs indicate that most of  the structures found are larger than peroxisomes  from control ceils, and several 
of the structures contain multiple membranes. 
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assembly display similar phenoWpes. Peroxisomes in complemen- 
ration group I and S. cerevisiae past are morphologically normal 
and  are  able to import  PTSl-containing  proteins but not PTS2- 
containing proteins into their matrix. In complementation group IV 
and S. cerevisiae  paslO, atypical membranous structures are pres- 
ent that are able to import PTS2- but not PTSl-containing proteins. 
NALD, neonatal form of adrenoleukodystrophy. 
thought to arise from an  inability  to synthesize plasmalo- 
gens: Wanders et al. have found a single enzyme deficiency 
of  dihydroxyacetonephosphate  acyRransferase  (1992)  or 
alkyldihydroxyacetonephosphate  synthase  (1993)  in  two 
RCDP patients.  The finding of additional complementation 
groups amongst RCDP patients (Moser, A., personal com- 
munication)  supports  the  view that  several  (at least four) 
genetic defects could give rise to impairedplasmalogen syn- 
thesis.  The apparent inconsistency between our results and 
those of Balfe et al.  may, therefore,  result from the use of 
RCDP cells belonging to different complementation groups. 
Again,  the phenotype of the group I  fibroblasts is strik- 
ingly similar to that of an S. cerevisiae mutant.  The peroxi- 
somes present  in both group I  fibroblasts  (Heikoop et al. 
1991) and S. cerevisiae pasT cells (Van der Leij et al.,  1992) 
are morphologically normal  and are  capable of importing 
PTSl-containing proteins and catalase but not thiolase into 
their matrix.  The number of proteins  entering  the peroxi- 
some via the PTS2 pathway appears to be rather limited com- 
pared to the number of proteins containing  the PTS1.  This 
may explain the difference in peroxisome morphology be- 
tween human complementatlon group I (S.  cerevisiae pasT) 
and group IV (S.  cerevisiae paslO). 
A generalized loss of import of PTS1- and PTS2-contain- 
ing proteins is illustrated by groups II, HI, and V. In these 
cells, only the routing of certain peroxisomal membrane pro- 
teins appears to be still functional.  The phenotype of these 
cells may reflect a generalized impairment  in the assembly 
or  maturation  of the  organelle.  Alternatively,  by analogy 
with the import system for rnitochondriai proteins, the defect 
may lie at a point at which the PTS1 and PTS2 import path- 
ways converge, for example, at the protein translocation ap- 
paratus. 
Complementation group V is a special case in this last cat- 
egory. The diffuse pattern of  fluorescence found after expres- 
sion of luciferase indicates the incapacity of the PTS1 import 
pathway.  Expression of prethiolase-CAT, however, gives rise 
to a weak punctate fluorescence in a fraction of the microin- 
jected cells.  The reason for this intermediate  phenotype is 
unclear. The mutation in Fujiki's group F has recently been 
shown to reside in the gene encoding the 35-kD PAF (peroxi- 
some assembly factor) (Shimozawa et ai.,  1992). Remark- 
ably, Shimozawa et ai. have found an identical mutation in 
PAF in our complementation  group V  (Shimozawa et al., 
1993). This mutation introduces a stop codon, giving rise to 
a  COOH-terminal  truncated  protein.  The  truncated  PAF 
protein may show some residual activity. Another possibility 
is  that  prethiolase-CAT  is  targeted  to  ghosts  in  group  V 
cells, but fails to be imported. The sensitivity of endogenous 
thiolase to proteinase K digestion in permeabilized group V 
cells supports this possibility. 
In  conclusion,  we  have  found  differential  import  deft- 
ciencies among the human peroxisome assembly disorders: 
the phenotypes  found are  analogous  to phenotypes found 
amongst the S. cerevisiae peroxisome assembly mutants (see 
Fig.  10).  The finding  that differential protein import defi- 
ciencies also occur in the human peroxisome assembly dis- 
orders  substantiates  further  that  the  mechanism  of per- 
oxisomal protein import is strongly conserved, not only in 
the use of similar targetting sequences, but also in the pro- 
teins comprising the import machinery. 
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